Dermata Therapeutics, Inc (DRMA)
1.21
+0.03 (2.54%)
Upcoming Events
Latest Headlines
Form S-8 Dermata Therapeutics,
June 4, 2026 4:16 PM - SEC Filing
Form SCHEDULE 13D Dermata Therapeutics, Filed by: Van Hoose Kyri K.
June 1, 2026 4:36 PM - SEC Filing
Form EFFECT Dermata Therapeutics,
June 1, 2026 6:08 AM - SEC Filing
Form 424B3 Dermata Therapeutics,
May 29, 2026 5:26 PM - SEC Filing
Form 8-K Dermata Therapeutics, For: May 27
May 27, 2026 4:58 PM - SEC Filing
Dermata Therapeutics, Inc (DRMA) files $100M mixed shelf
May 22, 2026 5:18 PM - StreetInsider
Form S-3/A Dermata Therapeutics,
May 22, 2026 5:16 PM - SEC Filing
Dermata Therapeutics, Inc (DRMA) Misses Q1 EPS by 48c
May 13, 2026 5:20 PM - StreetInsider
Form SCHEDULE 13G/A Dermata Therapeutics, Filed by: INTRACOASTAL CAPITAL, LLC
May 13, 2026 4:40 PM - SEC Filing
Form 10-Q Dermata Therapeutics, For: Mar 31
May 13, 2026 4:08 PM - SEC Filing
Form 8-K Dermata Therapeutics, For: Mar 31
May 13, 2026 4:06 PM - SEC Filing
Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the First Quarter 2026
May 13, 2026 4:05 PM - StreetInsider
RBC Capital Starts Dermata Therapeutics In (DRMA) at Outperform
April 23, 2026 4:13 PM - StreetInsider
Form SCHEDULE 13G/A Dermata Therapeutics, Filed by: BIGGER CAPITAL FUND L P
April 22, 2026 4:20 PM - SEC Filing
Form DEF 14A Dermata Therapeutics, For: Apr 17
April 21, 2026 9:08 AM - SEC Filing
Form ARS Dermata Therapeutics, For: Dec 31
April 17, 2026 5:05 PM - SEC Filing
Form DEFA14A Dermata Therapeutics,
April 17, 2026 5:03 PM - SEC Filing
Form DEF 14A Dermata Therapeutics, For: Apr 17
April 17, 2026 5:01 PM - SEC Filing
Form PRE 14A Dermata Therapeutics, For: Apr 06
April 7, 2026 9:31 AM - SEC Filing
Dermata gets Australian patent acceptance for dermal filler delivery system
April 2, 2026 8:33 AM - StreetInsider
Dermata Receives Notice of Acceptance of Australian Patent Application for Topical Application of Dermal Fillers with its Bioneedle Delivery System
April 2, 2026 8:31 AM - StreetInsider
Form 10-K Dermata Therapeutics, For: Dec 31
March 26, 2026 5:18 PM - SEC Filing
Form 8-K Dermata Therapeutics, For: Mar 26
March 26, 2026 5:17 PM - SEC Filing
Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Year Ended 2025
March 26, 2026 5:15 PM - StreetInsider
Form 4 Dermata Therapeutics, For: Feb 17 Filed by: Bedoya-Toro Munera Maria E
March 17, 2026 5:44 PM - SEC Filing
Full Article List
